Shinya Yamanaka and his collaborators 1st explained their breakthrough in 2006, which has since provided the scientific community with the tools to generate an endless way to obtain stem cells. Importantly, iPS cells are not linked to the ethical problems characteristic of embryonic cells. CiRA and Cellectis are preparing to combine the groundbreaking iPS technology with the genome engineering experience of Cellectis to rationally engineer the genome of the cells to be able to offer better control over their behavior. ‘This collaboration supports the approach developed by Cellectis with Ectycell, its subsidiary dedicated to the commercial uses of iPS cells,’ declared David Sourdive, Executive Vice President, Corporate Development for Cellectis.Feldman. This will reduce the risk of developing lymphedema. Arm mapping is usually part of a larger development toward reducing or getting rid of the necessity to remove a woman’s lymph nodes – – thereby reducing the incidence of lymphedema. Beginning in the 1990s, sentinel node biopsy utilized dye injected into the breast to focus on the sentinel lymph node, the gatekeeper to the axilla and the one most at risk for cancer spread. Today, the most recent analysis indicates that fewer sufferers want any lymph nodes taken out than previously thought. Even if the sentinel node is been shown to be positive, patients with early-stage breasts malignancy who are treated with lumpectomy, radiation and chemotherapy might not need to have any further lymph nodes removed.
CINJ scientist receives University of Texas award for cancer therapeutic research In recognition of efforts made in cancer therapeutic research, Joseph R.